Tacrolimus-induced tinea incognito

Cutis

Volumn 73, Issue 4, 2004, Pages 237-238

  Siddaiah, Narendra ^a   Erickson, Quenby ^b   Miller, Gea ^b   Elston, Dirk M ^c  

^a South Sound Inpatient Physicians   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; GRISEOFULVIN; PREDNISONE; TSUKUBAENOLIDE;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DERMATOMYCOSIS; FEMALE; HUMAN; LABORATORY TEST; MALE; PUSTULE; SCALP; SEBORRHEA; TINEA; TINEA CAPITIS; TINEA CORPORIS; TINEA INCOGNITO;

CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TACROLIMUS; TINEA;

EID: 2342522609     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Ive FA, Marks R. Tinea incognito. Br Med J. 1968;3:149-152.
2. Nopper A, Markus R, Esterly N. When it's not ringworm: annular lesions of childhood. Pediatr Ann. 1998;27:136-148.
3. Rist TS, Abele DC, Cares JM. Tinea faciale, an often mis-diagnosed clinical entity. South Med J. 1974;67:331-334.
4. Bekersky I, Fitzsimmons W, Tanase A, et al. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis. J Am Acad Dermatol. 2001;44:S17-S27.
5. Bergman J, Rico JM. Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg. 2001;20:250-259.
6. Ling MR. Topical tacrolimus and pimecrolimus: future directions. Semin Cutan Med Surg. 2001;20:268-274.